Drug Information

Drug General Information
Drug ID
D0T6EE
Former ID
DNCL001573
Drug Name
ACE-031
Indication Duchenne muscular dystrophy [ICD10:G71.0] Phase 2 [522999]
Company
Acceleron Pharma
Target and Pathway
Target(s) Growth/differentiation factor 8 Target Info Inhibitor [532125]
PANTHER Pathway TGF-beta signaling pathway
WikiPathways Hypertrophy Model
References
Ref 522999ClinicalTrials.gov (NCT01099761) Study of ACE-031 in Subjects With Duchenne Muscular Dystrophy. U.S. National Institutes of Health.
Ref 532125A single ascending-dose study of muscle regulator ACE-031 in healthy volunteers. Muscle Nerve. 2013 Mar;47(3):416-23.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.